Upfront Payments by Therapeutic Category
Executive Summary
One way a biotech might choose a therapeutic area of focus is by the value it could extract from a licensee. To get a handle on this value, we ranked the top therapeutic categories by total upfront money paid over the last 12 months, both in terms of equity and straight cash.